Medline Industries Files for IPO Targeting $5 Billion Raise in Largest Medical Supply Public Offering
核心洞察
Medline Industries (搜索), a major medical supply company based in Northfield, Illinois, has publicly filed for an initial public offering that could raise approximately $5 billion and value the company at up to $50 billion.
The company reported strong financial performance with net income of $655 million and net sales of $13.5 billion for the six months ending June 28, representing increases of 12% and 10% respectively from the previous year.
Private equity firms Blackstone, Carlyle Group (搜索), and Hellman & Friedman (搜索) acquired a majority stake in Medline in 2021 for approximately $34 billion and are now seeking to exit through this public offering.
Medline Industries (搜索), one of the world's largest medical supply companies, has publicly filed paperwork with the U.S. Securities and Exchange Commission for a proposed initial public offering that could raise approximately $5 billion and value the company at up to $50 billion. The Northfield, Illinois-based company's IPO filing represents a major step toward what could become the largest public offering in the United States this year.
Strong Financial Performance Drives Public Market Entry
The company demonstrated robust financial performance in its SEC filing, reporting net income of $655 million for the six months ending June 28, representing a 12% increase from the previous year. Net sales rose approximately 10% to $13.5 billion from $12.3 billion in the comparable period, underscoring the company's growth trajectory in the medical supply sector.
Medline manufactures and distributes hundreds of thousands of medical products, including patient gowns, medical supplies and instruments, personal protective equipment, and Curad bandages. The company is perhaps most recognizable for producing the iconic pink and blue striped blankets used to wrap newborns in hospitals across the country.
Private Equity Exit Strategy
The IPO represents an exit strategy for private equity firms Blackstone Group (搜索), Carlyle Group (搜索), and Hellman & Friedman (搜索), which acquired a majority stake in Medline from the founding Mills family (搜索) in June 2021. The Wall Street Journal reported that deal valued the company at approximately $34 billion, including debt.
According to the filing, proceeds from the IPO will be used for debt repayment and other general corporate purposes. Additional proceeds from any share sales under the underwriters' option will be used to redeem equity interests held by pre-IPO owners, including the financial sponsors and the Mills family (搜索), at the IPO price.
Market Context and Industry Impact
The medical supply sector has seen accelerated private equity exits in 2025, with 12 exits totaling $3.09 billion in the first 10 months of the year, compared to 14 deals worth $0.75 billion for all of 2024, according to PitchBook data. This uptick reflects improved public market valuations and a more favorable macroeconomic environment encouraging portfolio company exits.
Medline's IPO filing comes after the company initially submitted a confidential draft registration statement to the SEC in December 2024, but postponed the offering due to turbulent market conditions. The company now plans to list its shares on the Nasdaq Global Select Market under the symbol "MDLN."
Global Operations and Employment
With more than 43,000 employees worldwide, Medline maintains a significant presence in the Chicago area with nearly 6,100 employees across Cook and Lake counties. The company operates eight facilities in the Chicago region, including a flagship distribution center in Grayslake that employs approximately 850 people.
Leadership Commitment
CEO Jim Boyle emphasized the company's commitment to stakeholders in a note accompanying the filing, stating, "Becoming a public company is a responsibility that we take seriously. We will create value for our shareholders through our relentless customer focus, stellar execution, and commitment to long-term success."
Goldman Sachs (搜索), Morgan Stanley (搜索), BofA Securities (搜索), and JP Morgan (搜索) are serving as joint bookrunners for the offering. The company must wait at least 15 days after the public filing before beginning investor roadshow presentations, with trading potentially commencing once SEC approval is obtained and pricing is completed.